Literature DB >> 17513311

Group additive regression models for genomic data analysis.

Yihui Luan1, Hongzhe Li.   

Abstract

One important problem in genomic research is to identify genomic features such as gene expression data or DNA single nucleotide polymorphisms (SNPs) that are related to clinical phenotypes. Often these genomic data can be naturally divided into biologically meaningful groups such as genes belonging to the same pathways or SNPs within genes. In this paper, we propose group additive regression models and a group gradient descent boosting procedure for identifying groups of genomic features that are related to clinical phenotypes. Our simulation results show that by dividing the variables into appropriate groups, we can obtain better identification of the group features that are related to the phenotypes. In addition, the prediction mean square errors are also smaller than the component-wise boosting procedure. We demonstrate the application of the methods to pathway-based analysis of microarray gene expression data of breast cancer. Results from analysis of a breast cancer microarray gene expression data set indicate that the pathways of metalloendopeptidases (MMPs) and MMP inhibitors, as well as cell proliferation, cell growth, and maintenance are important to breast cancer-specific survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513311     DOI: 10.1093/biostatistics/kxm015

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  15 in total

1.  Buckley-James boosting for survival analysis with high-dimensional biomarker data.

Authors:  Zhu Wang; C Y Wang
Journal:  Stat Appl Genet Mol Biol       Date:  2010-06-08

2.  Studying gene and gene-environment effects of uncommon and common variants on continuous traits: a marker-set approach using gene-trait similarity regression.

Authors:  Jung-Ying Tzeng; Daowen Zhang; Monnat Pongpanich; Chris Smith; Mark I McCarthy; Michèle M Sale; Bradford B Worrall; Fang-Chi Hsu; Duncan C Thomas; Patrick F Sullivan
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

3.  Bayesian gene set analysis for identifying significant biological pathways.

Authors:  Babak Shahbaba; Robert Tibshirani; Catherine M Shachaf; Sylvia K Plevritis
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2011-08-01       Impact factor: 1.864

4.  Pathway aggregation for survival prediction via multiple kernel learning.

Authors:  Jennifer A Sinnott; Tianxi Cai
Journal:  Stat Med       Date:  2018-04-17       Impact factor: 2.373

5.  Confounded by sequencing depth in association studies of rare alleles.

Authors:  Chad Garner
Journal:  Genet Epidemiol       Date:  2011-05       Impact factor: 2.135

6.  Pathway index models for construction of patient-specific risk profiles.

Authors:  Kevin H Eng; Sijian Wang; William H Bradley; Janet S Rader; Christina Kendziorski
Journal:  Stat Med       Date:  2012-10-16       Impact factor: 2.373

7.  SBERIA: set-based gene-environment interaction test for rare and common variants in complex diseases.

Authors:  Shuo Jiao; Li Hsu; Stéphane Bézieau; Hermann Brenner; Andrew T Chan; Jenny Chang-Claude; Loic Le Marchand; Mathieu Lemire; Polly A Newcomb; Martha L Slattery; Ulrike Peters
Journal:  Genet Epidemiol       Date:  2013-05-29       Impact factor: 2.135

Review 8.  Gene module level analysis: identification to networks and dynamics.

Authors:  Xuewei Wang; Ertugrul Dalkic; Ming Wu; Christina Chan
Journal:  Curr Opin Biotechnol       Date:  2008-09-03       Impact factor: 9.740

9.  IPI59: An Actionable Biomarker to Improve Treatment Response in Serous Ovarian Carcinoma Patients.

Authors:  J Choi; S Ye; K H Eng; K Korthauer; W H Bradley; J S Rader; C Kendziorski
Journal:  Stat Biosci       Date:  2016-03-29

10.  Incorporating pathway information into boosting estimation of high-dimensional risk prediction models.

Authors:  Harald Binder; Martin Schumacher
Journal:  BMC Bioinformatics       Date:  2009-01-13       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.